The evolution of the so-called dread risk response has been explained by new research. People often respond to ...

UBS Global Healthcare Conference 2025 November 10, 2025 5:00 PM ESTCompany ParticipantsBrandon Perthuis - Chief ...

This article addresses the high failure rates in drug development, offering insights on improving clinical trials through AI ...

Aging brings about a range of changes—often unwelcome—to our bodies: sagging skin, graying or thinning hair, and a decline in muscle strength and ...

New MGX-001 preclinical data supports advancement into clinical development; Demonstrated curative FVIII activity in non-human primates ...

From cancer-resistant mole rats to 200-year-old whales, evolution has equipped long-lived species with unique biological ...

The landmark study demonstrates how intensive meditation can trigger the same profound brain activity previously documented only with psychedelic substances -- while simultaneously activating ...

Then David, who leads the Factor XI clinical program at Regeneron, will present preclinical data as well as clinical data from the ROXI-VTE-I and II studies in venous thromboembolism prevention post ...

SAB BIO Reports Third Quarter Financial Results And Recent Business Highlights. <li /> Initiated registrational Phase 2b SAFEGUARD trial of SAB-142 in new-onset, Stage 3 autoimmune T1D patients <li ...

Overview: The global Artificial Intelligence (AI) in drug discovery market is projected to grow at a rate of 25-30% over the next five years. Key factors driving this growth include the increasing ...